Vera Therapeutics, Inc. Class A Common Stock
$34.00
-$0.27 (-0.79%)
$33.08Day Range$34.56
Key Statistics
Market Cap
$2.45B
Shares Outstanding
72.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 14, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$34.56
Day High
$34.56
Day Low
$33.08
Volume
4.19M
VWAP
$33.94
Prev Close
$34.27
Transactions
--
Acc. Volume
--
About Vera Therapeutics, Inc. Class A Common Stock
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
PHARMACEUTICAL PREPARATIONSSIC 2834361 employees2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005650-770-0077IPO May 14, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001831828
- Composite FIGI
- BBG00Q72WYG3
- Share Class FIGI
- BBG00Q72WYH2
- Ticker Root
- VERA
- SIC Code
- 2834
About Vera Therapeutics, Inc. Class A Common Stock (VERA) Stock
Vera Therapeutics, Inc. Class A Common Stock (VERA) closed the 2026-09-18 session at $34.00, down 0.79% versus the previous close (-0.27). The stock opened at $34.56 and traded between $33.08 and $34.56 during that session. Session trading volume was 4.2M shares. The volume-weighted average price (VWAP) is $33.94.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Vera Therapeutics, Inc. Class A Common Stock has a market capitalization of $2.45 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. VERA is listed on the XNAS exchange. The company employs approximately 361 people. Vera Therapeutics, Inc. Class A Common Stock is headquartered in BRISBANE, CA. The recorded listing date is 2021-05-14.
On this page you can find market VERA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.